Belimumab Superior to Placebo in Yielding Systemic Lupus Erythematosus Responses
Ioannis Parodis, MD, PhD Credit: Research Gate A new meta-analysis has found that belimumab was superior to placebo according to BICLA criteria in patients with systemic lupus erythematosus (SLE).1 “The results from this post hoc analysis of foundational phase III SLE belimumab trials have important implications for clinical practice, as they substantiate the clinical efficacy … Read more